Partnering
Advantages to Our Partners • Collaborative Research Agreements
Our Strategy
Bioject is focused on forming strategic alliances with leading pharmaceutical, biotechnology and animal health companies. The company seeks to develop mutually beneficial agreements with these partners to develop customized injection systems to enhance the delivery of the partner's injected medication or vaccine.
Bioject is interested in working with a wide range of partners throughout the world in all
phases of scientific, technical development and commercialization, including:
- Biotechs
- Pharmaceutical companies, and
- Academic researchers and institutions
Bioject welcomes opportunities where our technology can enhance the delivery of
injectables for our partners in areas such as biologics, vaccines, small molecules and
technologies.
By using Bioject's needle-free technology, pharmaceutical and biotechnology partners can enhance their injected medications and vaccines in the many ways:
- Eliminates patient needle-phobia
- Extends product life cycles
- Differentiates injected products from competitors
- Protects caregiver from accidental needlestick injuries
In the animal health market, Bioject's offers safety features to not only the animal receiving the injection, but also the individual administering the vaccines.
Our broad base of applications can deliver:
- vaccines
- high viscosity meds
- proteins and peptides
- specialty drug therapies
- DNA- based therapies
Bioject has alliances with leading pharmaceutical, biotechnology, and animal health companies and currently has more than a dozen active collaborations with companies, research organizations, academia and the government.
 |
Merial |
 |
Ferring |
Business Development Information
Please contact Business Development at businessdevelopment@bioject.com